$TRDA
Entrada Therapeutics, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
$6.64
▼-1.63%-$0.110
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateEntrada Therapeutics, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is TRDA down today? It is at $6.64 (-1.63%), and our scanner flagged it 32 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment TRDA spikes, and full due diligence on TRDA — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $TRDA 32 times in the last 30 days. Create a free account to track $TRDA, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on TRDA from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for TRDA today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystEntrada Therapeutics, Inc.: Q2 FY2026 results, three months to Jun 30, 2026, from an SEC filing. Read it →Latest filingSC 13D/AActivist 5%+ stake updatedSep 10, 2026 · 11 days agoSources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Mpm Bioventures 2014, L.P. Beneficial Owner (10%) | Sold (automatic/other) | -29K 0.07% of company | sold 0.2% | 11.91M | $206K at $7.13 | Sep 9, 26 |
Mpm Bioventures 2018, L.P. Beneficial Owner (10%) | Sold (automatic/other) | -29K 0.07% of company | sold 0.2% | 11.91M | $206K at $7.13 | Sep 9, 26 |
Mpm Bioventures 2014, L.P. Beneficial Owner (10%) | Sold (automatic/other) | -193K 0.5% of company | sold 4.7% | 3.91M | $1.4M at $7.41 | Sep 8, 26 |
Mpm Bioventures 2018, L.P. Beneficial Owner (10%) | Sold (automatic/other) | -193K 0.5% of company | sold 4.7% | 3.91M | $1.4M at $7.41 | Sep 8, 26 |
Mpm Bioventures 2014, L.P. Beneficial Owner (10%) | Sold (automatic/other) | -39K 0.10% of company | sold 0.9% | 4.11M | $274K at $7.11 | Sep 4, 26 |
Mpm Bioventures 2018, L.P. Beneficial Owner (10%) | Sold (automatic/other) | -39K 0.10% of company | sold 0.9% | 4.11M | $274K at $7.11 | Sep 4, 26 |
Mpm Bioventures 2014, L.P. Beneficial Owner (10%) | Sold (automatic/other) | -32K 0.08% of company | sold 0.3% | 12.52M | $231K at $7.17 | Sep 3, 26 |
Mpm Bioventures 2018, L.P. Beneficial Owner (10%) | Sold (automatic/other) | -32K 0.08% of company | sold 0.3% | 12.52M | $231K at $7.17 | Sep 3, 26 |
Wentworth Kory James Officer | Sold (automatic/other) | -2K | sold 1.5% | 117K | $12K at $7.14 | Sep 2, 26 |
Sethuraman Natarajan Officer | Sold (automatic/other) | -2K | sold 1.0% | 214K | $15K at $7.14 | Sep 2, 26 |
Dowden Nathan J Officer | Sold (automatic/other) | -3K | sold 1.3% | 196K | $18K at $7.14 | Sep 2, 26 |
Doshi Dipal Officer | Sold (automatic/other) | -9K 0.02% of company | sold 1.7% | 517K | $62K at $7.14 | Sep 2, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on TRDA from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for TRDA today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
TRDA last traded at $6.64, down 1.63% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Entrada Therapeutics, Inc. Common Stock (TRDA) is next expected to report earnings on Thursday, November 5, 2026, about 45 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The TRDA Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged TRDA 32 times in the last 30 days.
TRDA (Entrada Therapeutics, Inc. Common Stock) trades on XNAS, with a market cap of about $259M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge TRDA for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$TRDA discussion
Sign in to ask a question or join the discussion.